In conclusion, our study not only advances our understanding of the role of USP52 in regulating ferroptosis and the Hippo–YAP signaling pathway in CRC but also underscores a potential combined ferroptosis inducer for enhancing immunotherapy. This evidence concerns the gene YAP1 and colorectal carcinoma.